NOS2 and myeloid sarcoma: However, in the case of c.1823 C > T (rs2297518) polymorphism of the NOS2 gene, we detected that the C/C genotype and the C allele were associated with increased MS risk, whereas the heterozygote and T/T homozygote, as well as T allele, reduced this risk.